Having trouble viewing this email? View it as a Web page. Agenda for April Drug Utilization Review Board Meeting Now Available The Texas Drug Utilization Review Board agenda for Friday, April 25, 2025, is now available. Other News: Change in PDL Status for the Immunomodulators, Atopic Dermatitis and Ophthalmics, Anti-Inflammatories Drug Classes, Effective April 4, 2025 Register Now for TMHP's Revalidation Extension and Retroactive Enrollment Period Webinars; Last Session Scheduled For May 1 Awareness and Testing Resources for Hepatitis Awareness Month This May March 2025 Specialty Drug List Available Pharmacy Education Reminders: Pharmacy Education Information and Opportunities Pharmacy Contact Information Must Be Current in PEMS

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to stevenmagallanes520.nims@blogger.com using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202